🇺🇸 FDA
Pipeline program

Surgery-radiotherapy

2018175

Unknown other active

Quick answer

Surgery-radiotherapy for Hepatocellular Carcinoma is a Unknown program (other) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Hepatocellular Carcinoma
Phase
Unknown
Modality
other
Status
active

Clinical trials